Microbot medical inc. (MBOT)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Operating activities:
Net loss

-7,491

-7,247

-7,503

-7,388

-7,739

-7,260

-6,721

-6,149

-7,764

-7,589

-14,573

-14,038

-10,694

-9,663

-1,491

16,451

8,153

-921

20,764

716

-2,937

-1,206

-29,455

-33,889

-27,642

-26,439

-22,235

-31,380

-24,678

-28,491

-32,944

-20,942

-25,810

-21,328

0

0

0

Adjustments to reconcile net loss to net cash flows from operating activities:
Interest and revaluation of convertible notes, net

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest and amortization of discount on convertible notes

-

-

-

-

-

-

-

-

-

-

-519

-

186

333

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Revaluation of convertible notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Financing loss on debt extinguishment

-

-

-

-

-

-

-

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Changes in fair value of derivative warrant liability

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Amortization of debt discount and issuance costs

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Gain on disposal of fixed assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

38

0

0

0

-

-

-

-

-32

0

0

0

Changes in fair value of derivative warrant liability

-

-

-

-

-

-

-

-

-

-

-536

-

-350

-

0

0

0

-

-

0

0

-

-2,922

1,296

-3,115

-3,253

0

0

0

-

-

-

-

-

-

-

-

Shares issued as consideration-vendor

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

90

84

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

1,320

1,258

1,155

1,058

962

942

959

991

1,050

1,116

1,174

1,207

0

0

0

Depreciation

-

-

-

-

-

-

-

32

25

21

16

16

12

10

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Share-based compensation expense

1,127

1,099

1,166

1,187

1,298

1,399

1,442

1,147

895

479

176

154

0

-

0

0

-

-

-

1,811

973

186

2,119

2,207

2,443

2,608

2,684

2,854

2,828

2,878

2,851

2,772

3,063

3,260

0

0

0

Changes in assets and liabilities:
Increase in restricted cash

-

-

-

-

-

-

-

0

-

-

0

0

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued interest and other receivables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

0

-

0

0

0

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

464

-554

-806

-801

-634

4

14

-22

-200

-676

-636

-495

0

0

0

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

16

7

29

-3

-47

-48

-35

50

-309

39

18

-67

0

0

0

Change in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

0

0

Other receivables

-

-

-

-

-

-

-

-117

-12

14

-343

-259

-427

-538

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-13

78

0

0

0

Other payables and accrued liabilities

0

-

0

0

0

-

-176

-413

-686

-69

206

679

931

324

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash flows from operating activities

-9,649

-6,451

-5,966

-5,967

-6,839

-5,310

-5,184

-5,201

-5,283

-4,856

-3,566

-2,638

-1,260

-786

0

0

0

-

-

-

-

-

-27,850

-27,169

-23,177

-23,322

-21,351

-19,584

-20,890

-19,869

-20,162

-19,642

-20,270

-22,058

0

0

0

Investing activities:
Purchase of property and equipment

0

-

-

-

-

223

269

254

169

58

53

53

47

25

0

-554

-219

2

-585

204

2

11

722

2,623

4,591

4,680

4,609

2,476

388

73

-14

197

284

296

0

0

0

Sales or maturities of marketable debt securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

Proceeds from sales of marketable security

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

-

-

-

-

Exercise of warrants

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

530

2,562

3,522

5,975

6,256

0

0

0

-

-

-

0

Sales of property and equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

38

0

0

0

-

-

-

-

-

0

0

0

Other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-493

-4

32

30

-89

-90

-88

-81

-76

0

0

0

Accounts payable and accrued expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

732

267

2,304

2,143

1,703

2,404

-43

-409

-1,340

-493

150

130

0

0

0

Accrued wind-down expense

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,102

1,317

1,497

1,190

1,032

1,161

1,272

1,188

1,165

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-57

1

-6

-24

-5

-19

-6

13

-15

-13

-11

-18

0

0

0

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

10

50

424

435

446

431

120

85

2,406

2,065

1,680

1,302

0

0

0

Net cash used for operating activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of marketable security

-

2,496

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

687

8,798

14,851

14,775

16,380

8,074

2,541

3,881

10,188

0

0

0

Acquisition of other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

64

0

0

0

-

-

-

-

-

-

-

-

Net cash flows from investing activities

2,496

-2,453

-2,480

-2,495

-2,586

-223

-242

-227

-169

-58

-80

-80

-47

-25

0

0

0

-

-

-

-

-

-846

-1,321

5,102

9,035

1,359

-2,263

-8,119

-10,691

-811

7,185

6,073

-3,422

0

0

0

Financing activities:
Outflow (inflow) in connection with current assets and liabilities acquired in reverse recapitalization, net

-

-

-

-

-

-

-

-399

-

-

-1,920

-1,920

-1,794

-2,002

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash used for investment activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Issuance of common stock and warrants, net of issuance costs

-

36,770

0

0

0

-

-

-2

-

12,702

12,704

12,704

3,290

0

0

0

0

-

-

-

-

-

-

-

-

23,491

0

0

0

-

-

-

-

19,774

0

0

0

Issuance of convertible notes

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

Net cash flows from financing activities

-

36,770

0

0

0

-

-

397

-

13,019

14,801

14,955

6,165

3,083

0

0

0

-

-

-

-

-

39,959

23,576

37,302

36,402

25,240

37,407

26,801

25,737

29,408

13,168

10,637

19,129

0

0

0

Increase (decrease) in cash, cash equivalents and restricted cash

20,055

27,866

1,098

1,082

119

-5,551

-5,056

-5,031

4,485

8,105

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Interest paid

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

540

589

558

427

281

131

45

50

54

59

65

71

0

0

0

Non-cash activities:
Cashless exercise of warrants issued upon conversion of notes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

11,155

-

-

-

0

0

0

-

-

-

-

-

-

0

0

-

5,248

15,559

-2,208

-4,824

8,434

711

-3,560

-6,350

0

0

0

Payments related to net share issuance of stock based awards

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

499

511

295

342

342

359

294

59

66

39

219

403

0

0

0

Repayment of capital lease obligations

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

20

19

15

12

8

5

3

20

36

52

69

67

0

0

0

Proceeds from the exercise of stock options

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

0

0

0

Proceeds from loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Repayment of loan payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

-

-

-

-

-

0

0

0

-

0

0

0

Net cash generated by financing activities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Increase (decrease) in cash and cash equivalents

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Effects of foreign exchange rate changes on cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-5

7

5

-2

-5

-9

-14

-15

-15

-41

-51

-45

0

0

0

Supplemental disclosure of cash flow information:
Cash received from interest

-

97

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cashless exercise of warrants

-

-

-

-

-

-

-

0

-

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Conversion of Series A Convertible Preferred Stock into common stock

-

-

-

-

-

-

-

-1,963

105

90

2,110

2,083

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Extinguishment of convertible notes in exchange for Series A Convertible Preferred Stock

-

-

-

-

-

-

-

-

-

-

0

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-